[EN] METHODS OF NAD+-DEPENDENT DEACETYLASE INHIBITORS<br/>[FR] METHODES D'UTILISATION D'INHIBITEURS DE DESACETYLASE NAD+ DEPENDANTE
申请人:GUILFORD PHARM INC
公开号:WO2005053609A2
公开(公告)日:2005-06-16
The present invention relates to methods of treating cancer, cardiovascular disorders, and neurological disorders using NAD+-dependent deacetylase inhibitors.